Company Overview and News

Roku's Long-Term Potential Is Unaffected By Amazon And Best Buy

2018-04-20 seekingalpha
TV is a commoditized business, it's not surprising to me that Insignia wants to differentiate. TCL is currently the dominant Roku TV brand.
Upvote Downvote

Amazon Teams Up with Best Buy to Boost Physical Presence

2018-04-19 zacks
Amazon (AMZN - Free Report) recently clinched a partnership deal with the electronic retailer, Best Buy (BBY - Free Report) to expand its product offering by introducing voice automated smart TVs. The idea behind the partnership is to integrate Amazon’s Fire TV with the smart TVs manufactured by Toshiba and Best Buy’s Insignia. Fire TV offers streaming and subscription services for the web series and movies from Netflix, Prime Video, HBO, PlayStation Vue, Hulu and many more.
Upvote Downvote

5 TV Stocks That Netflix Can’t Beat | InvestorPlace

2018-04-19 investorplace
There seems to be no letup in the powerful momentum with Netflix, Inc. (NASDAQ:NFLX). During the latest earnings report, revenues jumped by 43% and the company added 7.4 million new subscribers. The current membership base is now at 125 million.
Upvote Downvote

Amazon Targets Roku, Steals Away A Key Relationship With Best Buy

2018-04-19 seekingalpha
The event itself was predictable, the timing of the event more difficult. It was just a matter of time before significant competition from major companies began to increase for Roku.
Upvote Downvote

Best Buy Co Inc and, Inc. Partner on TV Sales

2018-04-19 investorplace, Inc. (NASDAQ:AMZN) and Best Buy Co Inc (NYSE:BBY) are fierce competitors. However, the two rivals just announced a historic partnership designed to leverage “showrooming” to their mutual benefit. Best Buy will begin carrying a new Amazon Fire Edition TV lineup in its stores, with Amazon Fire and Alexa integration. In addition, Best Buy will sell the smart TVs on, as a third-party seller.
Upvote Downvote

U.S. first-time unemployment claims dip to 232,000

2018-04-19 feeds.marketwatch
The total value of bonds in the lowest rung of the high-grade universe is bigger than the output of the world’s fifth-largest economy. Its growth is raising alarm bells for some analysts. Full Story
Upvote Downvote

Why Roku Inc Stock Could Be on a Clear Path to Rally to $50

2018-04-18 investorplace
Roku Inc (NASDAQ:ROKU) climbed about 1% in Monday’s regular-hours trading session but jumped in after-hours trading. Confirmation that the new streaming product from Walt Disney Co (NYSE:DIS), ESPN+, will be available on Roku devices was the driver. ROKU stock erupted Tuesday in response and was up more than 12% at one point in the session.
Upvote Downvote

Roku, Inc. (ROKU) Looks Good: Stock Adds 9% in Session

2018-04-18 zacks
Roku, Inc. (ROKU - Free Report) was a big mover last session, as the company saw its shares rise 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $30.29 to $34.73 in the past one-month time frame.
Upvote Downvote

FANG Is Leading The Charge - Cramer's Mad Money (4/17/18)

2018-04-18 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, April 17.
Upvote Downvote

Why Is Roku Surging Today?

2018-04-17 zacks
Roku (ROKU - Free Report) stock has risen more than 12% percent since yesterday’s close of $33.02. This burst can be credited to the announcement of a partnership with ESPN, which will run its new EPSN+ program through the Roku platform.
Upvote Downvote

Is This Move by Roku a Home Run?

2018-04-17 247wallst
Roku Inc. (NASDAQ: ROKU) shares made a solid gain on Tuesday after it was announced that the company would be taking on another partner. Specifically, Roku announced the availability of ESPN+ through the new ESPN channel on the Roku platform.
Upvote Downvote

3 Stocks to Watch on Tuesday: Celanese Corporation (CE), Roku Inc (ROKU) and Wintrust Financial Corp (WTFC) | InvestorPlace

2018-04-17 investorplace
The week started off with a bang for U.S. equities after fears of geopolitical tensions caused by the Syria missile strike calmed down. The S&P 500 Index gained 0.8%, the Dow Jones Industrial Average surged 0.9% and the Nasdaq Composite was up 0.7% at day’s end.
Upvote Downvote

ROKU / Roku Inc / Point72 Asset Management, L.P. - SCHEDULE 13G (Passive Investment)

240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto
Upvote Downvote

ROKU / Roku Inc / Point72 Asset Management, L.P. - SCHEDULE 13G (Passive Investment)

240.13d-102 Schedule 13G - Information to be included in statements filed pursuant to 240.13d-1(b), (c), and (d) and amendments thereto
Upvote Downvote

Missed A Hot IPO? Subscriptions Soar Towards 5 Million At This Startup

2018-04-14 seekingalpha
We'll discuss an opportunity to dip your toes into the warming waters of a new entertainment technology company, growing like a weed.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 77543R102